Food strategies of renal atrophy based on Avicenna and conventional medicine

10.1016/j.jtcme.2016.12.004

Marjan Mahjour；Arash Khoushabi；Maryam Miri Ghale Novi；Zohre Feyzabadi

Renal atrophy ； Food ； Avicenna ； Traditional Persian Medicine ； Hozal

Journal of Traditional and Complementary Medicine

7卷4期（2017 / 10 / 01）

375 - 379

英文

Kidneys have an important role in the body. Any damage to kidney role can damage many organs of the body. Traditional Persian Medicine (TPM) or Iranian traditional medicine (ITM) is an ancient temperamental medicine with many literatures about kidney diseases and Avicenna (980-1025 AD) describes kidney diseases in details. This is a review study by searching of the most important clinical and pharmaceutical TPM textbooks such as The Canon of Medicine by Avicenna and scientific data banks using keywords such as ＂Hozal-e-Kolye＂, renal atrophy, tubular atrophy, kidney, chronic kidney disease, and end stage renal disease. This paper found that ＂Hozal-e-Kolye＂ in TPM texts is the same tubular atrophy in conventional medicine due to some similar symptoms between them. Lifestyle modification and use of proposed foodstuffs can be considered as a complementary medicine in addition to conventional treatments to manage these patients. TPM scholars prescribed some foodstuffs such as camel milk, sheep's milk and Ficus carica for this disease as a complementary management. This study aimed to explain HK (the same tubular atrophy considering their similar symptoms) and introduce some food-stuffs. It seems using of foodstuffs affecting tubular atrophy based on TPM literatures can has a role as a supplemental method in company with conventional medicine management.

1. Tsai, W-H,Yang, C-C,Li, P-C,Chen, W-C,Chien, C-T(2013).Therapeutic potential of traditional chinese medicine on inflammatory diseases.J Tradit Complement Med,3,142.
   連結：
2. Wijesinghe, W,Pilapitiya, S,Hettiarchchi, P,Wijerathne, B,Siribaddana, S(2017).Regulation of herbal medicine use based on speculation? A case from Sri Lanka.J Tradit Complement Med,7(2),269-271.
   連結：
3. (2014).Manual of Pediatric Nephrology.Springer.
4. (2016).Manual of Nephrology.Jaypee Brothers, Medical Publishers Pvt. Limited.
5. (2008).Nutrition in Kidney Disease.Springer.
6. Adachi, T,Sugiyama, N,Yagita, H,Yokoyama, T(2014).Renal atrophy after ische-miaereperfusion injury depends on massive tubular apoptosis induced by TNFa in the later phase.Med Mol Morphol,47,213-223.
7. Aghaabasi, K,Baghizadeh, A(2015).Investigation of genetic diversity in flixweed (Descurainia sophia) germplasm from Kerman province using inter-simple sequence repeat (ISSR) and random amplified polymorphic DNA (RAPD) molecular markers.Afr J Biotechnol,11,10056-10062.
8. Aghili Alavi Khorasani, MH(2011).Makhzan-al-Adwiah.Tehran:Sabz Arang.
9. Amanzadeh, J,Reilly, RF(2006).Hypophosphatemia: an evidence-based approach to its clinical consequences and management.Nat Clin Pract Nephrol,2,136-148.
10. Aycock, RD,Kass, DA(2012).Urine: abnormal color.South Med J,105,43-47.
11. Barratt, J,Topham, P,Harris, KPG(2008).Oxford Desk Reference. Nephrology.Oxford University Press.
12. Bencini, R,Pulina, G(1997).The quality of sheep milk: a review.Anim Prod Sci.,37,485-504.
13. Beto, JA,Schury, KA,Bansal, VK(2016).Strategies to promote adherence to nutritional advice in patients with chronic kidney disease: a narrative review and commentary.Int J Nephrol Renovascular Dis,9,21.
14. Brufau, G,Boatella, J,Rafecas, M(2006).Nuts: source of energy and macronutrients.Br J Nutr,96,S24-S28.
15. Brull L, Dumont-Ruyters L, Firket J. Rickets and renal infantilism. Rev Belge Sci Medicales. 1941;13:129-150.
16. Caps, MT,Zierler, RE,Polissar, NL(1998).Risk of atrophy in kidneys with atherosclerotic renal artery stenosis.Kidney Int,53,735-742.
17. Chen, Y-p(2010).Experiences on the integrative medical diagnosis and treatment of acute kidney injury.Chin J Integr Med,16,207-212.
18. Clark, D,Georgitis, J,Ray, F(1981).Renal arterial injuries caused by blunt trauma.Surgery,90,87-96.
19. Clarke, TC,Black, LI,Stussman, BJ,Barnes, PM,Nahin, RL(2015).Trends in the use of complementary health approaches among adults: United States, 2002-2012.Natl Health Stat Rep,1
20. Davran, R,Helvaci, MR,Davarci, M(2014).Left renal atrophy.Int J Clin Exp Med,7,1603.
21. Emmett, JL,Alverez-Ierena, JJ,McDonald, JR(1952).Atrophic pyelonephritis versus congenital renal hypoplasia.J Am Med Assoc.,148,1470-1477.
22. Feyzabadi, Z,Jafari, F,Feizabadi, PS,Ashayeri, H,Esfahani, MM,Aval, SB(2014).Insomnia in Iranian traditional medicine.Iran Red Crescent Med J.,16,e15981.
23. Fukuda, M,Motokawa, M,Miyagi, S(2006).Polynocturia in chronic kidney disease is related to natriuresis rather than to water diuresis.Nephrol Dial Transplant,21,2172-2177.
24. Ghahraman, AOA(2004).Matching the Old Medicinal Plant Name with Scientific Terminology.Tehran:Tehran University Publisher.
25. Ghrairi, F,Lahouar, L,Brahmi, F,Ferchichi, A,Achour, L,Said, S(2013).Physicochemical composition of different varieties of raisins (Vitis vinifera L.) from Tunisia.Ind Crops Prod,43,73-77.
26. Hakim Mommen, M.(2010).Tuhfat-al Momenin.Qom:Noor vahy.
27. Hanif, M,Javed, H,Jallani, U,Ranjha, NM(2016).Prevalence of end stage renal disease in diabetic obese and hypertensive patients and cardiovascular risk in dialysis patients.Pak J Pharm Res.,2,42-48.
28. Harber, M(ed.)(2014).Practical Nephrology.London:Springer London.
29. Harvey, KB,Blumenkrantz, MJ,Levine, SE,Blackburn, GL(1980).Nutritional assessment and treatment of chronic renal failure.Am J Clin Nutr.,33,1586-1597.
30. Herring, JC,Enquist, EG,Chernoff, A,Linehan, WM,Choyke, PL,Walther, MM(2001).Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience.J Urol,165,777-781.
31. Ibn Sina, H(2005).Canon of Medicine.Beirut:Dar Ehya al-tarath al-arabi.
32. Ihle, BU,Becker, GJ,Whitworth, JA,Charlwood, RA,Kincaid-Smith, PS(1989).The effect of protein restriction on the progression of renal insufficiency.N Engl J Med,321,1773-1777.
33. Jha, V,Garcia-Garcia, G,Iseki, K(2013).Chronic kidney disease: global dimension and perspectives.Lancet,382,260-272.
34. Jiang, Z,Zhang, X,Yang, L,Li, Z,Qin, W(2016).Effect of restricted protein diet supplemented with Keto analogues in chronic kidney disease: a systematic review and meta-analysis.Int Urol Nephrol.,48,409-418.
35. Jorjani, EIH(2012).Zakhireye Khwarazmshahi.Ghom:Ehyaye Tebe Tabiee.
36. Jukanti, AK,Gaur, PM,Gowda, C,Chibbar, RN(2012).Nutritional quality and health benefits of chickpea (Cicer arietinum L.): a review.Br J Nutr,108,S11-S26.
37. Kalantar-Zadeh, K(2013).Patient education for phosphorus management in chronic kidney disease.Patient Prefer Adherence,7,379-390.
38. Kasper, DL,Fauci, AS,Hauser, SL,Longo, DL,Jameson, JL,Loscalzo, J.(2015).Harrison's Principles of Internal Medicine.United States:McGraw-Hill Companies.
39. Kovesdy, CP,Kalantar-Zadeh, K(2016).Back to the future: restricted protein intake for conservative management of CKD, triple goals of renoprotection, uremia mitigation, and nutritional health.Int Urol Nephrol.,48,725-729.
40. Kritchevsky, D,Weber, MM,Klurfeld, DM(1984).Dietary fat versus caloric content in initiation and promotion of 7, 12-dimethylbenz (a) anthracene-induced mammary tumorigenesis in rats.Cancer Res,44,3174-3177.
41. Kumar, KS,Bhowmik, D(2012).Traditional and medicinal uses of banana.J Pharmacogn Phytochem,1
42. Levey, AS,Coresh, J(2012).Chronic kidney disease.Lancet,379,165-180.
43. Loffroy, R,Guiu, B,Watfa, J,Michel, F,Cercueil, J,Krausé, D(2007).Xanthogranulomatous pyelonephritis in adults: clinical and radiological findings in diffuse and focal forms.Clin Radiol,62,884-890.
44. Mawa, S,Husain, K,Jantan, I(2013).Ficus carica L. (Moraceae): phytochemistry, traditional uses and biological activities.Evid Based Complement Altern Med,2013
45. McAfee, JG(1979).Radionuclide Imaging in the assessment of primary chronic pyelonephritis 1.Radiology,133,203-206.
46. McCarthy, JT(1999).A practical approach to the management of patients with chronic renal failure.Mayo Clinic Proceedings
47. McCord, BA(2002).Vegetarian Cooking for Starters.Crystal Clarity Publishers.
48. McDougall, J.(2009).Nuts come in hard shells-for reasons.McDougall Newsletter,November
49. Moreno, JA,Ramos, AM,Ortiz, A(2011).22 apoptosis in the kidney.Apoptosis Physiol Pathol.,240.
50. Nazem Jahan, MA(2008).Exire Azam.Tehran:Iran University of Medicine.
51. Neuringer, M,Connor, WE,Van Petten, C,Barstad, L(1984).Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys.J Clin Investig,73,272.
52. Raben, A,Agerholm-Larsen, L,Flint, A,Holst, JJ,Astrup, A(2003).Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake.Am J Clin Nutr,77,91-100.
53. Reilly Lukela, J,Van Harrison, R,Jimbo, M,Mahallati, A,Saran, R,Sy, AZ(2014).Reilly Lukela J, Van Harrison R, Jimbo M, Mahallati A, Saran R, Sy AZ. Management of chronic kidney disease. In: Guidelines for Clinical Care Ambulatory. 2014:1-27. University of Michigan: Clinical alignment & performance excellence. Taubman Medical Library..
54. Schelling, JR(2016).Tubular atrophy in the pathogenesis of chronic kidney disease progression.Pediatr Nephrol,31,693-706.
55. Shah Arzani Mir Mohammad, AM(2009).Teb-e-Akbari.Qom:Ehyaye Tebe Tabiee.
56. Textor, SC,Wilcox, CS(2001).Renal artery stenosis: a common, treatable cause of renal failure?.Annu Rev Med,52,421-442.
57. Thomson, I,Asadi karam, GR,Salem, Z(2009).Biochemical Compounds and Nutritional Roles of the Foods Explained in the Qur'an.Pak J Nutr,8,13-19.
58. Yuvaraj, A,Vijayan, M,Alex, M,Abraham, G,Nair, S(2016).Effect of high-protein supplemental therapy on subjective global assessment of CKD-5D patients.Hemodial Int.,20,56-62.